Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DZB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,051
Award facts
- Contract value 100% obligated
- $37,050.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,050.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL injections, with an ultimate completion date of January 30, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle through December 2031 that serves as the primary mechanism for supplying comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen, through its parent Cencora, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Cosentyx is a prescription biologic used primarily for autoimmune and inflammatory conditions, representing the type of specialty pharmaceutical products the company regularly supplies through its DLA contract vehicle to military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9DZB?
SPE2DR26F9DZB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9DZB worth?
The government has obligated $37,051 on SPE2DR26F9DZB.
Is contract SPE2DR26F9DZB an order under another contract?
Yes. SPE2DR26F9DZB is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DZB competed?
The extent of competition for SPE2DR26F9DZB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award